Acknowledgment and Consent for Disclosure of Section 712(c)(2)(B) of the Federal Food, Drug, and Cosmetic Act and 18 U.S.C. $208 Particular Matter Waivers Name: - Sugammadex - Document - PDFSEARCH.IO

First Page	Meta Content
	Acknowledgment and Consent for Disclosure of Section 712(c)(2)(B) of the Federal Food, Drug, and Cosmetic Act and 18 U.S.C. $208 Particular Matter Waivers Name: Add to Reading List Document Date: 2008-02-25 09:20:43 Open Document File Size: 27,41 KB Share Result on Facebook Company Organon USA / Schering-Plough Corporation / / Currency USD / / Organization FDA / Life Support Drugs Advisory Committee / / Person James C. Eisenach / / SocialTag Polysaccharides Pharmaceutical sciences Sugammadex Muscle relaxants Quaternary ammonium compounds Food and Drug Administration Schering-Plough Anesthetic Rocuronium bromide Medicine

Acknowledgment and Consent for Disclosure of Section 712(c)(2)(B) of the Federal Food, Drug, and Cosmetic Act and 18 U.S.C. $208 Particular Matter Waivers Name:Add to Reading List